Literature DB >> 18787195

Patterns of brain arteriovenous malformation treatment: prospective, population-based study.

Janneke van Beijnum1, Jo J Bhattacharya, Carl E Counsell, Vakis Papanastassiou, Vaughn Ritchie, Richard C Roberts, Robin J Sellar, Charles Warlow, Rustam Al-Shahi Salman.   

Abstract

BACKGROUND AND
PURPOSE: The extent of variation in the interventional treatment of brain arteriovenous malformations (AVMs) is unknown, so we explored patterns of treatment at 4 neuroscience centers in one European country.
METHODS: We included every participant with an AVM in a prospective, population-based cohort study of adults aged >or=16 years residing in Scotland at the time of AVM diagnosis in 1999 to 2003.
RESULTS: Only 11 (5%) of the 229 adults were not managed at a neuroscience center. Adults who received interventional treatment were younger (median, 43 versus 54 years), more likely to have presented with hemorrhage (OR, 2.8; 95% CI, 1.6 to 4.9), and had smaller AVMs (median nidus diameter, 2 cm versus 3 cm; P=0.003) than those who did not. Adults seen at the 4 centers only differed in AVM Spetzler-Martin grade (P=0.04). The 4 centers did not differ in the proportion of adults with AVMs who received interventional treatment (P=0.16), but they differed in the Spetzler-Martin grade of the AVMs they treated (Grades III to IV, P=0.01) and the interventional treatments used (P=0.004). The 2 largest centers differed from each other in the likelihood of surgical resection (OR, 0.2; 95% CI, 0.1 to 0.6) and stereotactic radiosurgery (OR, 2.8; 95% CI, 1.3 to 6.1), and the choice of modality varied within some Spetzler-Martin grades.
CONCLUSIONS: Patient characteristics and patterns of AVM interventional treatment differ between neuroscience centers in the same population necessitating careful consideration of these factors when comparing one hospital's outcome with another.

Entities:  

Mesh:

Year:  2008        PMID: 18787195     DOI: 10.1161/STROKEAHA.108.523662

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Multimodality treatment approach in children with cerebral arteriovenous malformation--a survey in the Danish population.

Authors:  Jane Skjøth-Rasmussen; Tina Obbekjær; Peter Birkeland; John Hauerberg; Marianne Juhler
Journal:  Childs Nerv Syst       Date:  2011-12-08       Impact factor: 1.475

Review 2.  Management of unbled brain arteriovenous malformation study.

Authors:  J P Mohr; Shadi Yaghi
Journal:  Neurol Clin       Date:  2015-05       Impact factor: 3.806

3.  The effect of age on arteriovenous malformations in children and young adults undergoing magnetic resonance imaging.

Authors:  Thomas M O'Lynnger; Wajd N Al-Holou; Joseph J Gemmete; Aditya S Pandey; B Gregory Thompson; Hugh J L Garton; Cormac O Maher
Journal:  Childs Nerv Syst       Date:  2011-03-26       Impact factor: 1.475

4.  Acute management of brain arteriovenous malformations.

Authors:  Andreas Hartmann; J P Mohr
Journal:  Curr Treat Options Neurol       Date:  2015-05       Impact factor: 3.598

5.  A case of complex arteriovenous malformation with skull destruction presented in sixth decade of life.

Authors:  Stevo Lukic; Mirjana Spasic; Zoran Peric; Dejan Savic; Slobodan Vojinovic; Dragan Stojanov; Srdjan Ljubisavljević
Journal:  Neurol Sci       Date:  2011-01-14       Impact factor: 3.307

6.  The ARUBA trial: current status, future hopes.

Authors:  J P Mohr; Alan J Moskowitz; Christian Stapf; Andreas Hartmann; Karen Lord; Steven M Marshall; Henning Mast; Ellen Moquete; Claudia Scala Moy; Michael Parides; John Pile-Spellman; Rustam Al-Shahi Salman; Alan Weinberg; William L Young; Alejandrina Estevez; Inam Kureshi; Jonathan L Brisman
Journal:  Stroke       Date:  2010-07-15       Impact factor: 7.914

7.  Trends in the management of intracranial vascular malformations in the USA from 2000 to 2007.

Authors:  Jae H Choi; John Pile-Spellman; Jonathan Brisman
Journal:  Stroke Res Treat       Date:  2012-02-27

8.  Infarct volume after glioblastoma surgery as an independent prognostic factor.

Authors:  Stefanie Bette; Benedikt Wiestler; Johannes Kaesmacher; Thomas Huber; Julia Gerhardt; Melanie Barz; Claire Delbridge; Yu-Mi Ryang; Florian Ringel; Claus Zimmer; Bernhard Meyer; Tobias Boeckh-Behrens; Jan S Kirschke; Jens Gempt
Journal:  Oncotarget       Date:  2016-09-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.